CONR
Conor Medsystems Inc
Cardiovascular device company focused on drug-eluting stents (DES) for the treatment of coronary artery disease; developed the CoStar paclitaxel-eluting stent
CUSIP: 208264101HealthcareUS1 holder
Conor Medsystems Inc
Cardiovascular device company focused on drug-eluting stents (DES) for the treatment of coronary artery disease; developed the CoStar paclitaxel-eluting stent
No Schedule 13D or 13G filings recorded.